Kazia Therapeutics Ltd ADR ( KZIA) - Key Metrics
KZIA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$3.95 | -$2.91 | -$2.91 |
| 2025Q4 | $0.01 | -$6.41 | -$2.67 | $0 |
| 2025Q2 | $0.03 | -$12.29 | -$4.95 | -$4.95 |
| 2024Q4 | $4.31 | -$31.21 | -$5.64 | -$5.64 |
| 2024Q2 | $0 | -$18.40 | -$13.21 | -$13.21 |
KZIA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.65 |
| 2025Q4 | 0% | -0.37 |
| 2025Q2 | 0% | -0.58 |
| 2024Q4 | 0% | -0.13 |
| 2024Q2 | 0% | -0.45 |
KZIA
Price: $7.25
52 week price:
Earnings Per Share: -7.68 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 38900
Market Capitalization: 15.0 million